Crook, S., Basic Principles of Antisense Therapeutics, Springer-Verlag Berlin Heidelberg New York, Jul. 1998. |
Gura T., Antisense Has Growing Pains, Science, vol. 270, pp. 575-577, Oct. 1995. |
Crooke, S. et al., Antisense '97: A roundtable on the state of the industry, Nature Biotechnology, vol. 15, p.522, Jun. 1997. |
Branch, A., A Good antisense molecule is hard to find, TIBS vol. 23, pp 47-49, Feb. 1998. |
Ahmad et al., "Antisense Expression of Protein Kinase C.alpha. Inhibits the Growth and Tumorigenicity of Human Glioblastoma Cells", Neurosurg., 1994, 35, 904-908. |
Bacher, N. et al., "Isolation and Characterization of PKC-L, A New Member of the Protein Kinase C-Related Gene Family Specifically Expressed in Lung, Skin, and Heart", Mol. Cell. Biol., 1991, 11, 126-133. |
Ballester, R. et al., "Fate of Immunoprecipitable Protein Kinase C in GH.sub.3 Cells Treated with Phorbol 12-Myristate 13-Acetate", J. Biol. Chem., 1985, 260(28),15194-15199. |
Baxter et al., "PKC-episilon is involved in granulocyte-macrophage colong-stimulating factor signal transduction: Evidence from microphysiometry and antisense oligonucleotide experiments", Biochemistry, 1992, 31, 10950-10954. |
Berkowitz, P.T. et al., "Synthesis of 1,2-Dihydro-1-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-2-oxopyrizine 4-Oxide, a Potent Analog of Deoxyuridine", J. Med. Chem., 1973, 16, 813-814. |
Borek, C. et al., "Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse C3H/10T1/2 cells treated with radiation and phorbol 12-myristate 13-acetate", Proc. Natl. Acad. Sci., 1991, 88, 1953-1957. |
Brandt, S.J. et al., "Distinct Patterns of Expression of Different protein Kinase C mRNAs in Rat Tissues", Cell, 1987, 49, 57-63. |
Coussens et al., "Multiple, Distinct Forms of Bovine and Human Protein Kinase C Suggest Diversity in Cellular Signaling Pathways", Science, 1986, 233, 859-866. |
Endo, et al., "Cell Membrane Signaling as Target in Cancer Therapy: Inhibitory Effect of N,N-Dimethyl and N,N,N-Trimethyl Sphingosine Derivatives on In Vitro and In Vivo Growth of Human Tumor Cells in Nude Mice", Cancer Research, 1991, 51, 1613-1618. |
Farese et al., "Antisense DNA downregulates protein kinase C isozymes (beta and alpha) and insulin-stimulated 2-deoxyglucose uptake in rat adipocytes", Antisense Res. Dev., 1991, 1(1), 35-42. |
Finkenzeller, G., "Sequence of Human Protein Kinase C .alpha.", Nucleic Acids Research, 1990, 18(8), 2183. |
Gescher, A. et al., "Protein Kinase C-A Novel Target for Rational Anti-Cancer Drug Design", Anti-Cancer Drug Design, 1989, 4, 93-105. |
Godson, et al., "Inhibition of Expression of Protein Kinase C .alpha. by Antisense cDNA Inhibits Phorbol Ester-Mediated Archidonate Release", J. Biol. Chem., 1993, 268, 11946-11950. |
Hackh's Chemical Dictionary, Grant, et al. (ed.), McGraw-Hill Book Company, New York, p. 312. |
Hegemann, L. et al., Pharmacology of the Skin, H. Mukhtar (ed.), CRC press, Boca Raton, FL, 1992, pp. 357-368. |
Hidaka, H. et al., "Pharmacology of the isoquinoline sulfonamide protein kinase C inhibitors", TIPS, 1987, 8, 162-164. |
Maister, Bioworld Today, Apr. 29, 1994, p. 3. |
Kubo, K. et al., "Primary structures of human protein kinase CBI and BII differ only in their C-terminal sequences", FEBS Letters, 1987, 223(1), 138-142. |
Krug, E. et al., "Evidence for increased synthesis as well as increased degradation of protein kinase C after treatment of human ostersarcoma cells with phorbol ester", J. Biological Chemistry, 1987, 262(24), 11852-11856. |
Standaert et al., J. Cellular Biochem., 1991, (Keystone Symposia on Molecular and Cellular Biology, Jan. 18-25), Suppl. 15B, p.26, abstract CA 211. |
Maier, J.A.M. et al., "An Oligomer Targeted against Protein Kinase C.alpha. Prevents Interleuken-1.alpha. Induction of Cyclooxygenase Expression in Human Endothelial Cells", Exp. Cell Res., 1993, 205, 52-58. |
Marcus-Sekura, C.J., "Techniques for Using Antisense Oligodeosyribonucleotides to Study Gene Expression", Analyt. Biochem., 1988, 172, 289-295. |
Nielsen, P.E. et al., "Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide", Science, 1991, 254, 1497-1500. |
Nishizuka, Y., "The Molecular Heterogeneity of Protein Kinase C and its Implications for Cellular Regulation", Nature, 1988, 334:661-665. |
Osada, S. et al., "A phorbol ester receptor/protein kinase, nPKC.eta., a new member of the protein kinase C family predominantly expressed in lung and skin", J. Biol. Chem., 1990, 265(36), 22434-22440. |
Parker et al., "The complete primary stucture of protein kinase c--the major phorbol ester receptor", Science, 1986, 233, 853-866. |
Rothenberg, M. et al., "Oligodeoxynucleotides as Anti-Sense Inhibitors of Gene Expression: Therapeutic Implications", J. Natl. Cancer Inst., 1989, 81, 1539-1544. |
Sakanoue, Y. et al., "Protein Kinase C Activity as Marker for Colorectal Cancer", Int. J. Cancer, 1991, 48, 803-806. |
Sambrook et al. (eds.), Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 10.59. |
Simons, M. et al., "Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo", Nature, 1992, 359, 67-70. |
Catalog of Products for DNA Research, Glen Research, Sterling, VA, 1993, p. 21. |
Watson, J.D. et al., "The Two Chains of the Double Helix Have Complementary Sequences", 1988, Molecular Biology of the Gene, Benjamin/Cummings Publishing Co., Inc., Menlo Park, CA, 241. |
Webster's II New Riverside University Dictionary, Soukkhanov et al., (Eds.), Houghton Mifflin Company, Boston, MA, 1984, p. 68. |
Weinstein, I.B., "Cancer Prevention: Recent Progress and Future Opportunities", Cancer Research, 1991, 51, 5080s-5085s. |
Young, S. et al., "Down-regulation of protein kinase C is due to an increased rate of degradation", Biochem., 1987, 244, 775-779. |
Zon, G., "Oligonucleotide Analogues as Potential Chemotherapeutic Agents", Pharm. Res., 1988, 5, 539-547. |
Greenberg, M.E. in Current Protocols in Molecular Biology, Ausubel et al. (Eds.), John Wiley & Sons, NY, 1987. |
Kawasaki et al., "Synthesis and Biophysical Studies of 2'-dRIBO-F Modified Oligonucleotides", Conference on Nucleic Acid Therapeutics, Clearwater, FL, Jan., 1991. |
Boyce et al., Neurosci. Res. Commun., 1996, 18(3), 195-201. |
Dean et al., Proc. Annu. Meet. Assoc. Cancer Res., 1995, 36, 413, Abstract 2460. |
Gura, T., "Antisense has Growing Pains", Science, 1995, 270, 575-577. |
Henderson, C.W. (Publ.), Infectious Disease Weekly, Oct. 23, 1995. |
Martin, P., "Ein neuer Zugang zu 2'-O-Alkylribonucleosiden und Eigenschaften deren Oligonucleotide", Helvetica Chemica Acta, 1995, 78, 486-504. |
Ono, Y. et al., "The Structure, Expression, and Properties of Additional Members of the Protein Kinase C Family", J. Biol. Chem., 1988, 263, 6927-6932. |
Orkin et al., "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy", Dec. 7, 1995. |
PR Newswire Association, Inc., PR Newswire, Aug. 1, 1996, p. 0801LATH014. |
Uhlmann, E. et al., "Antisense Oligonucleotides: A New Therapeutic Principle", Chem. Reviews, 1990, 90, 544-584. |